The cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI) and there was no benefit to the patients' quality of life, ...
Aug 30, 2024
0
1
Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of sudden cardiac death (SCD). With an estimated incidence as high as 22% among these patients, current clinical guidelines ...
Jul 29, 2024
0
0
Every year, around 50,000 people in the United States experience cardiogenic shockâa life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood for the body's needs.
Feb 14, 2024
0
15
Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a study published in the Jan. ...
Jan 18, 2024
0
0
A multi-institution research effort led by Harvard Medical School, Boston, has looked into the safety and efficacy of excluding aspirin from the treatment of patients with advanced heart failure receiving a fully magnetically ...
The traditional Chinese medicine qiliqiangxin reduces hospitalization for heart failure and cardiovascular death in patients with heart failure and a reduced ejection fraction (HFrEF), according to late breaking research ...
Aug 28, 2023
0
3
Breast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likelihood of patients experiencing cardiovascular side effects, like cardiotoxicity, are not well-known ...
Aug 2, 2023
1
8
The three-decade-old international cutpoint for diagnosing children and adolescents with an enlarged heart misclassifies normal heart size as cardiac damage in adolescents, a paper published in the American Journal of Physiology-Heart ...
Mar 2, 2023
0
3
The complications experienced by heart failure patients implanted with a left ventricular assist device (LVAD) vary depending on socioeconomic factors, according to a Rutgers-led study.
Sep 21, 2022
0
26
Dapagliflozin reduces the risk for worsening heart failure or cardiovascular death, regardless of frailty status, according to a study published online April 26 in the Annals of Internal Medicine.
Apr 26, 2022
0
2
